Key facts
- This page summarizes Chad M. Cohen's Form 4 filing for Adaptive Biotechnologies Corp (ADPT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Dec 2021, 20:00.
Chad M. Cohen - 22 Dec 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ADPT
- Reported as of
- 22 Dec 2021
- Net transaction value
- -$227,300
- SEC form
- 4
- Accepted by SEC
- 23 Dec 2021, 20:00:16 UTC
- Prior SEC filing
- 07 Dec 2021
- Next SEC filing
- 25 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Chad Cohen by Eric Billings, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Chad M. Cohen filed Form 4 for Adaptive Biotechnologies Corp (ADPT) on 23 Dec 2021.
Change
- Previous filing in this sequence was filed on 07 Dec 2021.
- Current net transaction value: -$227,300.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADPT
transaction
Common Stock
Options Exercise
- Transaction value
- $72,700
- Shares
- +10,000
- Change %
- +46%
- Price
- $7.27
- Shares after
- 31,604
- Date
- 22 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
ADPT
transaction
Common Stock
Sale
- Transaction value
- $300,000
- Shares
- -10,000
- Change %
- -32%
- Price
- $30.00
- Shares after
- 21,604
- Date
- 22 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ADPT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -11%
- Price
- $0.000000
- Shares after
- 80,000
- Date
- 22 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $7.27
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
Footnote F2
The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.